Noah Goodman sold $387K of KYMR stock

Noah Goodman, Chief Business Officer of Kymera Therapeutics, Inc. (KYMR), sold 3,389 shares of KYMR stock worth $387K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 1, 2026, 1 day before it was made public.

KYMR has moved +11.7% since the trade date, from $114.20 to $127.57 (Nov 13, 2026 close).